Canadian Licensed producers of marijuana to benefit from cost accounting court battle
Posted on
February 17, 2015 by
Dr. Luc Duchesne
In a Vancouver courtroom on February 23, 2015 at 9:30 AM PST, the entire Canadian cannabiz industry and 40,000 licensed medical marijuana users, will hold their collective breath as four people have put and may still put an entire industry at a standstill by challenging the right of the Government of Canada to dictate how individuals can provide for their own medicine cost-effectively.
One of four Applicants in Neal Allard et al v. Her Majesty The Queen, Mr Neil Allard, a patient with legitimate needs for medical marijuana, estimates that to maintain his current dosage through a Licensed Producer at a cost of $8-10 per gram would cost approximately $6,000 per month, and $3,000 at a cost of $5 per gram. Until the implementation of the MMPR regulations in Canada, Mr Allard has a license to produce his own medical marijuana at a cost of $0.5 per gram under the MMAR regulations.
Forcing Mr Allard to buy medical marijuana, he argues in court documents, would compel him to pay costs that far exceed his monthly income either now or upon his retirement, and these costs are not eligible for assistance under any health care plan. Given these increased costs, Mr. Allard fears that he may have to risk imprisonment by continuing to produce marihuana or procuring it through the illicit market.
The Applicants’ case is at the center of a controversy that stalled the progress of marijuana industry since its filing in March 2014 a mere few weeks before the MMPR system was supposed to fully displace the leaky MMAR system. By leaky I mean that the lack of regulatory control of the MMAR system permitted medical marijuana to enter the illicit market.
- See more at:
http://investorintel.com/potash-phosphate-intel/canadian-licensed-producers-marijuana-benefit-cost-accounting-court-battle/#sthash.V0tHe6ic.dpuf
